APGE

APOGEE THERAPEUTICS INC

APGE·03770N101·US·Common Stock·Healthcare - Biotechnology-Activist

APGE (APOGEE THERAPEUTICS INC) is held by 135 institutional investors as of Q1 2026. Largest holders: FMR LLC ($779.6M), WELLINGTON MANAGEMENT GROUP LLP ($368.3M), BlackRock, Inc. ($343.9M). Net institutional sentiment: Bullish.

135
Holders
(24 Elite)
$4.1B
Total Value
70% (140)
Consensus
98 buying - 42 selling
13F: Insider & Congress:
APGESmart Money Verdict
View all
Held by 135 funds
24 elite
Who's Trading
ActivistTRT. Rowe Price Investment Management, Inc.1.3%Jul 8, 2026
ActivistWellington Management Group LLPWellington Management Group LLP0.9%Jul 8, 2026
ActivistFMR LLCFMR LLC4.0%Jul 8, 2026
ActivistFAFairmount Funds Management LLC9.8%Jun 23, 2026
InsiderDCDambkowski CarlExercise 4K shMay 6, 2026
InsiderDCDambkowski CarlSell $311KMay 6, 2026
InsiderDCDambkowski CarlSell $152KMay 6, 2026
InsiderHJHenderson JaneSell $66KMay 1, 2026
InsiderHJHenderson JaneSell $74KMay 1, 2026
InsiderHJHenderson JaneSell $24KMay 1, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9.3M(+12.6%)$779.6M0.0%+158.49%
36
Decreased
4.4M(-7.8%)$368.3M0.1%+211.24%
0
Increased
4.1M(+8.0%)$343.9M0.0%+144.69%
34
Increased
2.8M(+2.6%)$234.2M2.3%+355.39%
54
New
2.5M$210.6M0.0%+95.11%
42
Increased
2.4M(+14.4%)$198.8M0.1%+94.41%
35
Increased
2.2M(+28.0%)$182.1M0.0%+145.80%
38
Decreased
1.9M(-12.0%)$161.7M1.2%+223.56%
0
Increased
1.2M(+14.9%)$102.5M0.0%+166.93%
34
Increased
1.1M(+17.4%)$96.3M0.0%+166.89%
35
Decreased
1.1M(-7.6%)$96.2M0.0%+148.41%
0
Increased
1.1M(+121.6%)$89.6M0.9%+116.74%
68
Decreased
1.1M(-19.1%)$87.4M0.0%+187.63%
0
Increased
900,871(+13.5%)$75.8M0.0%+123.33%
34
Decreased
990,297(-9.4%)$74.7M0.0%+146.68%
0
Decreased
831,428(-6.7%)$70M0.1%+221.56%
0
Increased
652,590(+15.4%)$54.9M0.0%+183.05%
34
Decreased
598,902(-21.9%)$50.4M0.0%+222.78%
0
Decreased
595,032(-33.2%)$50.1M0.0%+134.82%
0
Increased
585,016(+1.1%)$49.2M0.0%+76.60%
30

Showing 1-20 of 143

1 / 8

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used